Cytogenetically Normal Acute Myeloid Leukaemia (CN-AML): Favourable Prognosis of NPM1 Mutation may have Linkage with High Expression of HOXA and PBX3 Genes

被引:0
|
作者
Akhter, Ariz [1 ]
Elyamany, Ghaleb [2 ]
Roshan, Tariq [3 ]
Mansoor, Adnan [1 ]
机构
[1] Univ Calgary, Calgary, AB, Canada
[2] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[3] Univ Calgary, Alberta Precis Labs, Calgary, AB, Canada
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1065
引用
收藏
页码:S1084 / S1085
页数:2
相关论文
共 36 条
  • [1] NPM1 mutations as an independent prognosticator for older cytogenetically normal acute myeloid leukemia (CN AML)
    Becker, H.
    Marcucci, G.
    Maharry, K.
    Margeson, D.
    Radmacher, M. D.
    Whitman, S. P.
    Mrozek, K.
    Baer, M. R.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Heritable polymorphism predisposes to high expression of BAALC in cytogenetically normal acute myeloid leukemia (CN-AML)
    Eisfeld, Ann-Kathrin
    Marcucci, Guido
    Liyanarachchi, Sandya
    Doehner, Konstanze
    Schwind, Sebastian
    Maharry, Kati
    Nicolet, Deedra
    Radmacher, Michael D.
    Doehner, Hartmut
    Tanner, Stephan M.
    Bloomfield, Clara D.
    de la Chapelle, Albert
    CANCER RESEARCH, 2012, 72
  • [3] Cytogenetically Normal Acute Myeloid Leukaemia (CN-AML) in Young Adults: High Expression of ATM serine/threonine kinase (ATM) Gene has Prognostic Implications
    Kamran, Hamza
    Akhter, Ariz
    Elyamany, Ghaleb
    Roshan, Tariq
    Mansoor, Adnan
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1164 - S1164
  • [4] MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
    Isabella Faraoni
    Serena Laterza
    Davide Ardiri
    Claudia Ciardi
    Francesco Fazi
    Francesco Lo-Coco
    Journal of Hematology & Oncology, 5
  • [5] MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
    Faraoni, Isabella
    Laterza, Serena
    Ardiri, Davide
    Ciardi, Claudia
    Fazi, Francesco
    Lo-Coco, Francesco
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [6] Prognostic impact of NPM1 mutations in cytogenetically normal (CN) acute myeloid leukemia (AML) is adversely affected by high expression of the ERG gene:: A cancer and leukemia group B (CALGB) study
    Paschka, P.
    Marcucci, G.
    Maharry, K.
    Whitman, S. P.
    Ruppert, A. S.
    Vukosavljevic, T.
    Mrozek, K.
    Powell, B. L.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 145
  • [7] Higher MN1 expression is an unfavorable prognosticator in older patients (Pts) with cytogenetically normal acute myeloid leukemia (CN-AML): A CALGB study
    Schwind, Sebastian
    Marcucci, Guido
    Holland, Kelsi B.
    Mrozek, Krzysztof
    Michael, Radmacher D.
    Maharry, Kati
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Carter, Thomas H.
    Powell, Bayard L.
    Caligiuri, Michael A.
    Baer, Maria R.
    Larson, Richard A.
    Bloomfield, Clara D.
    CANCER RESEARCH, 2010, 70
  • [8] IDH1 AND IDH2 GENE MUTATIONS ARE FREQUENT MOLECULAR LESIONS IN ACUTE MYELOID LEUKEMIA (AML) AND CONFER ADVERSE PROGNOSIS IN CYTOGENETICALLY NORMAL AML WITH NPM1 MUTATION WITHOUT FLT3-ITD
    Paschka, P.
    Schlenk, R.
    Gaidzik, V.
    Habdank, M.
    Kroenke, J.
    Bullinger, L.
    Spaeth, D.
    Kayser, S.
    Zucknick, M.
    Goetze, K.
    Horst, H.
    Germing, U.
    Doehner, H.
    Doehner, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 456 - 456
  • [9] The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia
    Rashidi, Armin
    Wolach, Ofir
    El-Jawahri, Areej
    Ho, Vincent T.
    DiPersio, John F.
    Soiffer, Robert
    Stone, Richard M.
    Chen, Yi-Bin
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1977 - 1979
  • [10] Low Meningioma 1 (MN1) gene expression to predict outcome in cytogenetically normal acute myeloid leukemia (CN-AML): A Cancer and Leukemia Group B (CALGB) study
    Langer, C.
    Maharry, K.
    Mrozek, K.
    Paschka, P.
    Whitman, S. P.
    Kolitz, J. E.
    Larson, R. A.
    Marcucci, G.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)